Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR133A1 host gene (MIR133A1HG) is a long non-coding RNA on human chromosome 18 that serves as the primary transcript (host gene) for the production of the muscle-specific microRNA miR-133a-1[3][4][6]. The host gene itself does not encode a protein and its specific functions—apart from giving rise to miR-133a-1—are not well characterized[6]. Diseases linked to MIR133A1HG primarily reflect the functions of its microRNA product, and include leukemias and inflammatory diseases[3]. MIR133A1HG is officially recognized as a lncRNA gene by gene databases[3][6]. There are no known direct drug interactions, mechanisms of action, biomarker roles, or specific safety/therapeutic considerations related to MIR133A1HG itself; most research focuses on miR-133a-1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR133A1 host gene (non-protein coding) (MIR133A1HG).